Short Interest in Nihon Kohden Corporation (OTCMKTS:NHNKY) Declines By 61.7%

Posted by on Aug 30th, 2026

Nihon Kohden Corporation (OTCMKTS:NHNKY – Get Free Report) saw a significant decrease in short interest in August. As of August 14th, there was short interest totaling 2,205 shares, a decrease of 61.7% from the July 30th total of 5,764 shares. Based on an average daily volume of 18,091 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the shares of the stock are short sold.

Nihon Kohden Trading Up 1.1%

Nihon Kohden stock traded up $0.10 during mid-day trading on Friday, hitting $9.36. The stock had a trading volume of 8,653 shares, compared to its average volume of 8,706. The stock has a 50-day simple moving average of $9.34 and a two-hundred day simple moving average of $9.53. The stock has a market capitalization of $1.57 billion, a PE ratio of 17.02 and a beta of 0.37. Nihon Kohden has a 12 month low of $8.12 and a 12 month high of $14.21.

Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.09). The business had revenue of $297.47 million for the quarter, compared to analyst estimates of $299.98 million. Nihon Kohden had a net margin of 5.90% and a return on equity of 9.08%. Sell-side analysts expect that Nihon Kohden will post 0.6 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, UBS Group lowered shares of Nihon Kohden from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 12th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, Nihon Kohden currently has an average rating of “Hold”.

Check Out Our Latest Stock Analysis on Nihon Kohden

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

Featured Stories

Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.